Drug Type Monoclonal antibody |
Synonyms ADG125, BC-006, BC006 |
Target |
Action inhibitors |
Mechanism INHBE inhibitors(inhibin subunit beta E inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |










| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Phase 2 | China | 02 Feb 2026 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 18 Sep 2021 | |
| Giant Cell Tumor of Tendon Sheath | Phase 1 | China | 18 Sep 2021 |






